Search clinical trials for: Dosing time

Total 11092 results

Kos Pharmaceuticals

Completed

Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication

Intermittent Claudication | Peripheral Vascular Disease
Advancis Pharmaceutical Corporation

Completed

APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat

Tonsillitis | Pharyngitis | Sore Throat

United States, Canada
Advancis Pharmaceutical Corporation

Completed

APC-231 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) in Pediatric Patients With Strep Throat

Pharyngitis

United States
Eli Lilly and Company

Completed

Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolescents

Attention Deficit Hyperactivity Disorder

Sweden
Royal Marsden NHS Foundation Trust

Unknown

Dual Time Point PET Imaging in Lymphoma

Hodgkin's or Non-Hodgkin's Lymphoma
Eisai Inc.

Completed

Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients

Breast Neoplasms | Metastases

United States, Canada
Bayside Health
Victorian Trauma Foundation

Unknown

Is Sensory Stimulation Effective in Reducing Time Spent in a Coma or Vegetative State

Traumatic Brain Injury

Australia
Newcastle University
Newcastle Primary Care Trust

Completed

Translating Clinicians' Beliefs Into Implementation Interventions (TRACII)

URTI | Upper Respiratory Tract Infection

United Kingdom
University Hospital Tuebingen
Joachim Riethmueller, Dr. med.

Unknown

Time of Ventilation and Lung Function of Ventilated Patients Under Therapy With Dornase Alfa

Long Term Ventilation

Germany
Hamamatsu University
Yokoyama Foundation for Clinical Pharmacology

Unknown

Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori

Gastritis | Helicobacter Infections | Gastric Ulcer | Duodenal Ulcer

Japan
National Institute of Environmental Health Sciences...
Tufts Medical Center

Completed

Air Pollution and Implantable Cardioverter Defibrillators

Arrythmias

United States
University of Bristol

Completed

Feasibility of n-of-1 Trials - a Pilot Study

Osteoarthritis

United Kingdom
Jikei University School of Medicine
Novo Nordisk A/S

Unknown

Jikei Optimal Insulin Therapy in Type 2 Diabetes

Diabetes Mellitus, Type 2

Japan
LifeBridge Health

Unknown

Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin

Coronary Artery Disease

United States
Eli Lilly and Company

Completed

Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Canada
National Taiwan University Hospital

Unknown

A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely

Staphylococcal Infections

Taiwan
University of Glasgow
Equity Partners (University Challenge Fund)

Unknown

Effect Site Controlled, Reaction Time Safeguarded, Patient Maintained Sedation With Propofol in Anxious Patients

Surgery | Dental Anxiety | Colonoscopy | Oral Surgical Procedures | Surgery, Oral

United Kingdom
Sheba Medical Center

Unknown

Genotyping of Cytomegalovirus From Patients in Israel

Cytomegalovirus Infections

Israel
Abbott

Completed

Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)

Renal Insufficiency, Chronic

United States, Poland
Abbott

Completed

Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)

Renal Insufficiency, Chronic

United States, Poland
Abbott

Completed

Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)

Renal Insufficiency, Chronic

United States, Poland
Eli Lilly and Company

Completed

Local Registration Trial in China Humalog Mix 50

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

China
Laboratoires Thea

Completed

Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma

Trachoma
Tawam Hospital

Unknown

Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia

B-Cell Chronic Lymphocytic Leukemia
Eli Lilly and Company
Boehringer Ingelheim

Completed

Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.

Stress Urinary Incontinence

United States
Eli Lilly and Company

Completed

Duloxetine in the Treatment of Melancholic Depression

Depressive Disorder, Major

Australia, Canada
Eli Lilly and Company

Completed

Switching to Duloxetine From Other Antidepressants

Major Depressive Disorder

Spain, France, Ireland, United Kingdom
Eli Lilly and Company

Completed

Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode

Bipolar Disorder

Spain
Eli Lilly and Company

Completed

Olanzapine in Patients With Borderline Personality Disorder

Borderline Personality Disorder

Germany, United States, Belgium, France, Norway, Portugal, Spain, Sweden, United Kingdom
Eli Lilly and Company

Completed

A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Disorder With Hyperactivity

United States
Eli Lilly and Company

Completed

Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder

Borderline Personality Disorder

United States, Argentina, Poland, Romania, Turkey
Eli Lilly and Company

Completed

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

Major Depressive Disorder

United States, Canada
Eli Lilly and Company

Completed

Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy

Carcinoma, Non-Small-Cell Lung

Russian Federation
Eli Lilly and Company

Completed

Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain

Depression | Pain

United States
Eli Lilly and Company

Completed

Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression

Major Depressive Disorder

United States
University of Toronto

Unknown

A Study of the Effect of Time on Topical Anesthetic Efficacy.

Pain

Canada
Centers for Disease Control and Prevention
Peking University; University of Florida; Ministry of Science and Technology...

Completed

Blood Folate and Homocysteine Levels Following Administration of Folic Acid According to Different Daily Dosing Schedules:a Simulation of Food Fortification

Neural Tube Defects - Spina Bifida and Anencephaly

China
Romanian Society of Nephrology

Completed

Epoetin Dosing Regimens in Haemodialysis

Hemodialyzed Patients | Epoetin Treatment

Romania
University Hospital, Clermont-Ferrand

Completed

Impact of Systemic Corticosteroid Therapy on Lens Transparency and Quantification of Lens Autofluorescence.

Patients With Systemic Inflammatory Diseases Receiving for the First Time a Protracted General Corticostroid Therapy

France
KU Leuven
Novo Nordisk A/S; Fund for Scientific Research, Flanders, Belgium

Completed

KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients

Critical Illness

Belgium
University Hospital Tuebingen
Humboldt-Universität zu Berlin; University of Greifswald; Herzzentrum Bad Krotzingen

Unknown

Thunder Trial - Local Taxan With Short Time Contact for Reduction of Restenosis in Distal Arteries

Arterial Occlusive Diseases

Germany
Nizam's Institute of Medical Sciences University...

Completed

Influence of Hydroxyehtyl Starch (HES) on Hemorehology, Coagulation and Elimination Kinetics

Stroke Patients Presenting Within 24 Hrs of Onset of Symptoms
VA Connecticut Healthcare System
US Department of Veterans Affairs

Completed

Patient Position and Impact on Colonoscopy Time

Colonoscopy

United States
Papageorgiou General Hospital

Completed

Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism
National Taiwan University Hospital

Unknown

Comparison of Colonoscopy and Sigmoidoscopy in Terms of Pain, Acceptance and Procedure Time

Pain

Taiwan
Academy of Finland
Tampere University; Hospital District of Helsinki and Uusimaa; Coxa, Hospital... and other collaborators

Unknown

Study on Costs and Effects of Waiting Time in Total Hip and Knee Replacements

Osteoarthritis, Knee | Osteoarthritis, Hip

Finland
Lawson Health Research Institute

Unknown

Comparison of the Effects of Phenylephrine and Norepinephrine on Cardiac Function During Carotid Artery Surgery

Echocardiography, Transesophageal | Vasopressor Agents | Endarterectomy, Carotid

Canada
Montefiore Medical Center

Completed

A Trial Comparing Different Dosing Regimens of Morphine in Patients With Moderate to Severe Pain

Pain

United States
University of Glasgow
South Glasgow University Hospitals NHS Trust; The Stroke Association, United...

Completed

SELESTIAL: Trial of Insulin to Control Blood Sugar After Acute Stroke Using Magnetic Resonance Imaging (MRI) End-Points

Hyperglycemia | Acute Stroke

United Kingdom

Search clinical trials for: Dosing time

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations